The global demand for Live VaccinesMarket is presumed to reach the valuation of nearly USD XX BN by 2026 from USD XX BN in 2020 with a CAGR of XX% under the study period of 2019- 2026.
Live vaccines are extracted from disease causing viruses or bacterial strains which are attenuated or weekend by repeated culturing. Once an individual body is injected, then body develops immune and targets the infectious disease. These vaccines are helpful, which requires short dose and a single dose. These provide lifetime immunity against the respective diseases such as smallpox, influenza, hepatitis B and rabies. Introduction of advanced technology including live recombinant vaccine, which is generally used for infectious diseases. In 2017, near about 10.0 million cases were diagnosed with tuberculosis across the world. This market is driven due to the increasing prevalence of infectious disease including typhoid.
Rising prevalence of infectious disease, product launches, increasing healthcare expenditure and increased resistance to existing therapies are the key factors that drive the market demand. In addition to this, increasing strategic developments such as partnerships and agreements, and rising government initiative program for eradication of diseases through vaccination is anticipated to fuel the market growth within upcoming time zone. Though, emerging technology of routes of vaccine delivery such as inhaled vaccine and delivery of influenza vaccine is created lucrative opportunities for live vaccines market in the coming year. However, high costs involved in research and development may hamper the market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of eachtype, route of administration, application, and patientsegment in the global market of live vaccines.
The entire live vaccines market has been sub-categorized into type, route of administration, application, and patient. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Route of Administration
- Combination of injection &oral
- Yellow Fever
- Oral Polio
This section covers regional segmentation which accentuates on current and future demand for live vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Live Vaccines Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the live vaccinesmarket include Merck & Co., GlaxoSmithKline plc, Pfizer Inc., Astellas Pharma Inc., Emergent BioSolutions, AstraZeneca plc, Serum Institute of India Pvt. Ltd., Bharat Biotech, Sun Pharmaceutical Industries Limited, and Cipla Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.